Antimetabolite [EPC]

Antimetabolite [EPC] was reported 98853 times

Drugs of the Antimetabolite [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 GRANULOMATOUS ROSACEA 14 0.2857
1 ACUTE CHEST SYNDROME 176 0.2002
2 ANGIODERMATITIS 15 0.1765
3 DIFFERENTIATION SYNDROME 102 0.1390
4 ESSENTIAL THROMBOCYTHAEMIA 47 0.1274
5 LEUKOSTASIS SYNDROME 15 0.1128
6 PRIMARY MYELOFIBROSIS 32 0.0994
7 SICKLE CELL ANAEMIA WITH CRISIS 1503 0.0953
8 NAIL PIGMENTATION 23 0.0950
9 MYELOFIBROSIS 275 0.0908
10 SICKLE CELL DISEASE 41 0.0887
11 MYELOPROLIFERATIVE NEOPLASM 52 0.0784
12 POLYCYTHAEMIA VERA 57 0.0696
13 HYPERLEUKOCYTOSIS 59 0.0666
14 SICKLE CELL ANAEMIA 39 0.0605
15 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 74 0.0600
16 ERYTHROMELALGIA 20 0.0546
17 BLAST CELL COUNT INCREASED 56 0.0534
18 CYTOGENETIC ANALYSIS ABNORMAL 55 0.0525
19 PLATELET COUNT INCREASED 657 0.0503
20 BONE MARROW RETICULIN FIBROSIS 12 0.0465
21 PHILADELPHIA CHROMOSOME POSITIVE 34 0.0465
22 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 20 0.0448
23 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 29 0.0442
24 ERYTHROPOIESIS ABNORMAL 12 0.0392
25 HYPERSPLENISM 19 0.0384
26 SPLENOMEGALY 433 0.0369
27 CHRONIC MYELOMONOCYTIC LEUKAEMIA 24 0.0364
28 CHRONIC MYELOID LEUKAEMIA 168 0.0364
29 MYELOID LEUKAEMIA 18 0.0359
30 THROMBOCYTOSIS 130 0.0354
31 CHRONIC MYELOID LEUKAEMIA RECURRENT 19 0.0347
32 MARROW HYPERPLASIA 22 0.0323
33 HAEMATOCRIT INCREASED 72 0.0316
34 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 23 0.0314
35 THROMBOCYTHAEMIA 16 0.0288
36 BLAST CELLS PRESENT 13 0.0270
37 MYELODYSPLASTIC SYNDROME TRANSFORMATION 14 0.0269
38 SPLENIC INFARCTION 46 0.0263
39 BLOOD IRON INCREASED 49 0.0261
40 HAEMATOCRIT ABNORMAL 32 0.0260
41 RETICULOCYTE COUNT INCREASED 21 0.0260
42 SERUM FERRITIN INCREASED 136 0.0258
43 ACTINIC KERATOSIS 66 0.0254
44 FULL BLOOD COUNT INCREASED 30 0.0252
45 SPLEEN DISORDER 40 0.0236
46 ACUTE MYELOID LEUKAEMIA 358 0.0229
47 ACUTE LEUKAEMIA 37 0.0229
48 ANISOCYTOSIS 15 0.0228
49 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 16 0.0209
50 GRAFT VERSUS HOST DISEASE IN SKIN 45 0.0204
51 RED BLOOD CELL COUNT INCREASED 55 0.0199
52 BASOPHIL COUNT INCREASED 15 0.0198
53 TUMOUR LYSIS SYNDROME 174 0.0198
54 PLATELET COUNT ABNORMAL 118 0.0195
55 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 18 0.0195
56 IRON OVERLOAD 19 0.0176
57 ACUTE MYELOID LEUKAEMIA RECURRENT 37 0.0172
58 HAEMOGLOBIN INCREASED 77 0.0169
59 RED BLOOD CELL COUNT ABNORMAL 24 0.0163
60 EXTREMITY NECROSIS 28 0.0160
61 SEPTIC EMBOLUS 13 0.0156
62 WHITE BLOOD CELL COUNT INCREASED 596 0.0155
63 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 14 0.0151
64 PARAINFLUENZAE VIRUS INFECTION 23 0.0151
65 SQUAMOUS CELL CARCINOMA OF SKIN 90 0.0149
66 ANAEMIA MACROCYTIC 31 0.0145
67 PACKED RED BLOOD CELL TRANSFUSION 19 0.0144
68 URETEROLITHIASIS 15 0.0143
69 LEUKAEMIA RECURRENT 24 0.0142
70 LEUKOCYTOSIS 255 0.0141
71 NAIL DISCOLOURATION 55 0.0140
72 SQUAMOUS CELL CARCINOMA 129 0.0137
73 HEPATOSPLENOMEGALY 35 0.0136
74 CYTOMEGALOVIRUS INFECTION REACTIVATION 60 0.0136
75 PLATELET DISORDER 34 0.0135
76 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 28 0.0131
77 TRISOMY 21 16 0.0127
78 TRANSPLANT FAILURE 30 0.0122
79 DERMATOMYOSITIS 31 0.0122
80 MEAN CELL VOLUME INCREASED 31 0.0121
81 HYPERPHOSPHATAEMIA 25 0.0116
82 BLOOD LACTATE DEHYDROGENASE INCREASED 184 0.0116
83 SKIN ULCER 295 0.0114
84 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 19 0.0112
85 MACROCYTOSIS 13 0.0112
86 BLOOD URIC ACID INCREASED 62 0.0107
87 JUGULAR VEIN THROMBOSIS 19 0.0107
88 EARLY SATIETY 20 0.0103
89 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 17 0.0101
90 PLATELET TRANSFUSION 13 0.0101
91 BLOOD COUNT ABNORMAL 152 0.0100
92 ADENOVIRUS INFECTION 29 0.0100
93 HAEMOGLOBIN ABNORMAL 64 0.0099
94 BONE MARROW DISORDER 30 0.0099
95 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 23 0.0099
96 WHITE BLOOD CELL COUNT ABNORMAL 63 0.0099
97 SPLENIC RUPTURE 16 0.0097
98 WHITE BLOOD CELL DISORDER 26 0.0097
99 NEUTROPENIC COLITIS 20 0.0097
100 STENOTROPHOMONAS INFECTION 13 0.0096
101 HYPERURICAEMIA 39 0.0095
102 SECOND PRIMARY MALIGNANCY 78 0.0094
103 HAEMOGLOBIN DECREASED 952 0.0093
104 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 13 0.0092
105 GENE MUTATION 18 0.0091
106 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 25 0.0090
107 HAEMATOCRIT DECREASED 179 0.0090
108 BONE MARROW TRANSPLANT 17 0.0090
109 LEUKAEMIA 83 0.0088
110 VENOOCCLUSIVE DISEASE 22 0.0088
111 FULL BLOOD COUNT ABNORMAL 89 0.0084
112 RED BLOOD CELL COUNT DECREASED 240 0.0084
113 ACUTE GRAFT VERSUS HOST DISEASE 37 0.0081
114 ENTEROCOCCAL INFECTION 38 0.0079
115 PRIAPISM 27 0.0078
116 BILIRUBIN CONJUGATED INCREASED 18 0.0077
117 SOFT TISSUE INFECTION 14 0.0076
118 PRURITUS GENITAL 18 0.0076
119 SERUM FERRITIN DECREASED 13 0.0075
120 PORTAL VEIN THROMBOSIS 24 0.0074
121 RED CELL DISTRIBUTION WIDTH INCREASED 30 0.0072
122 MONOCYTE COUNT INCREASED 26 0.0072
123 APLASIA 14 0.0071
124 LUNG CONSOLIDATION 20 0.0071
125 IDIOPATHIC INTRACRANIAL HYPERTENSION 16 0.0071
126 GRAFT VERSUS HOST DISEASE 51 0.0071
127 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 18 0.0070
128 CYTOPENIA 85 0.0069
129 TONGUE ULCERATION 23 0.0068
130 BACTERIAL SEPSIS 22 0.0067
131 MIXED LIVER INJURY 20 0.0066
132 MYELODYSPLASTIC SYNDROME 96 0.0066
133 PLATELET COUNT DECREASED 706 0.0066
134 VARICES OESOPHAGEAL 20 0.0066
135 PNEUMONIA FUNGAL 26 0.0066
136 FEBRILE NEUTROPENIA 434 0.0065
137 VENTRICULAR HYPOKINESIA 21 0.0065
138 HEPATOMEGALY 64 0.0065
139 BLOOD DISORDER 51 0.0064
140 BASAL CELL CARCINOMA 99 0.0063
141 APLASTIC ANAEMIA 33 0.0063
142 POLYCYTHAEMIA 13 0.0063
143 EMERGENCY CARE 19 0.0063
144 PULMONARY ALVEOLAR HAEMORRHAGE 35 0.0062
145 SUBDURAL HAEMORRHAGE 17 0.0062
146 TRANSFUSION 65 0.0062
147 MUCOSAL INFLAMMATION 161 0.0061
148 CHRONIC GRAFT VERSUS HOST DISEASE 22 0.0061
149 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 58 0.0061
150 ESCHERICHIA BACTERAEMIA 14 0.0059
151 BRONCHOPULMONARY ASPERGILLOSIS 46 0.0059
152 PANCYTOPENIA 329 0.0059
153 BONE MARROW FAILURE 119 0.0058
154 DISSEMINATED INTRAVASCULAR COAGULATION 82 0.0058
155 HYPERBILIRUBINAEMIA 60 0.0058
156 NEUTROPHIL COUNT INCREASED 59 0.0058
157 INCREASED TENDENCY TO BRUISE 53 0.0058
158 STEM CELL TRANSPLANT 14 0.0056
159 FOETAL GROWTH RESTRICTION 34 0.0056
160 DISCOURAGEMENT 13 0.0056
161 ANAEMIA 1060 0.0056
162 FIBROSIS 17 0.0055
163 PORTAL HYPERTENSION 17 0.0055
164 HAEMOLYSIS 42 0.0054
165 THROMBOCYTOPENIA 608 0.0054
166 LUNG INFILTRATION 48 0.0054
167 CYTOLYTIC HEPATITIS 18 0.0054
168 HEPATITIS FULMINANT 16 0.0054
169 HYPERSENSITIVITY VASCULITIS 14 0.0053
170 ACUTE RESPIRATORY FAILURE 102 0.0053
171 BLOOD LOSS ANAEMIA 12 0.0053
172 PRODUCT AVAILABILITY ISSUE 119 0.0052
173 MULTIPLE-DRUG RESISTANCE 16 0.0052
174 FULL BLOOD COUNT DECREASED 102 0.0051
175 HAEMORRHAGIC DIATHESIS 18 0.0051
176 CONCOMITANT DISEASE AGGRAVATED 31 0.0050
177 BRAIN HERNIATION 15 0.0050
178 CORONAVIRUS INFECTION 33 0.0050
179 DRUG RESISTANCE 128 0.0050
180 NORMAL NEWBORN 27 0.0050
181 WOUND COMPLICATION 17 0.0049
182 CAROTID ARTERY OCCLUSION 18 0.0049
183 IRON DEFICIENCY 22 0.0049
184 BLOOD IRON DECREASED 58 0.0049
185 CACHEXIA 25 0.0049
186 PRODUCT USE COMPLAINT 76 0.0048
187 SUBDURAL HAEMATOMA 69 0.0048
188 EPSTEIN-BARR VIRUS INFECTION 30 0.0048
189 NIGHT SWEATS 154 0.0048
190 SKIN HYPERPIGMENTATION 41 0.0048
191 KLEBSIELLA INFECTION 24 0.0047
192 PIGMENTATION DISORDER 29 0.0047
193 VENOOCCLUSIVE LIVER DISEASE 23 0.0047
194 PULMONARY HAEMORRHAGE 36 0.0046
195 BLOOD BILIRUBIN INCREASED 124 0.0046
196 NEUTROPHILIA 26 0.0046
197 HAEMATOLOGICAL MALIGNANCY 13 0.0046
198 HAEMORRHAGE SUBCUTANEOUS 16 0.0045
199 HAEMOLYTIC ANAEMIA 40 0.0045
200 VASCULITIS 52 0.0045
201 BK VIRUS INFECTION 15 0.0044
202 ACUTE RESPIRATORY DISTRESS SYNDROME 78 0.0044
203 PULMONARY HYPERTENSION 91 0.0044
204 ULCER 69 0.0043
205 GANGRENE 26 0.0043
206 PERICARDIAL EFFUSION 99 0.0043
207 FLANK PAIN 40 0.0043
208 NASAL POLYPS 21 0.0043
209 DECREASED ACTIVITY 46 0.0043
210 ACUTE LYMPHOCYTIC LEUKAEMIA 12 0.0042
211 SKIN CANCER 90 0.0042
212 OCULAR ICTERUS 18 0.0041
213 BACTERAEMIA 49 0.0041
214 PLEURAL EFFUSION 251 0.0041
215 BLOOD UREA INCREASED 69 0.0041
216 BLOOD ALKALINE PHOSPHATASE INCREASED 102 0.0041
217 LEFT VENTRICULAR DYSFUNCTION 27 0.0040
218 AORTIC STENOSIS 14 0.0040
219 MUSCLE HAEMORRHAGE 16 0.0040
220 CEREBROVASCULAR DISORDER 12 0.0040
221 EMBOLISM VENOUS 12 0.0040
222 ENDOCARDITIS 20 0.0039
223 PERIPHERAL VASCULAR DISORDER 20 0.0039
224 BLOOD POTASSIUM INCREASED 63 0.0039
225 CEREBRAL HAEMATOMA 13 0.0039
226 LEFT VENTRICULAR FAILURE 13 0.0038
227 FEBRILE BONE MARROW APLASIA 16 0.0038
228 ENERGY INCREASED 22 0.0037
229 PRODUCT DOSE OMISSION 242 0.0037
230 GLOSSITIS 13 0.0037
231 IMMUNODEFICIENCY 54 0.0036
232 RALES 21 0.0036
233 SKIN MASS 24 0.0036
234 CARDIAC MURMUR 31 0.0036
235 OLIGURIA 22 0.0035
236 HAEMATOMA 91 0.0035
237 CLOSTRIDIUM DIFFICILE COLITIS 37 0.0035
238 SKIN NECROSIS 18 0.0035
239 INTERNATIONAL NORMALISED RATIO DECREASED 14 0.0035
240 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 14 0.0034
241 CARDIOMEGALY 42 0.0034
242 MOUTH HAEMORRHAGE 25 0.0034
243 CONJUNCTIVAL HAEMORRHAGE 13 0.0034
244 LIPASE INCREASED 26 0.0034
245 CYTOMEGALOVIRUS VIRAEMIA 15 0.0034
246 BLOOD TEST ABNORMAL 47 0.0033
247 GOUT 60 0.0033
248 RHINOVIRUS INFECTION 13 0.0033
249 WHITE BLOOD CELL COUNT DECREASED 362 0.0033
250 HYDRONEPHROSIS 25 0.0033
251 PHLEBITIS 17 0.0033
252 GENERALISED OEDEMA 41 0.0033
253 CYTOMEGALOVIRUS INFECTION 55 0.0033
254 CARDIAC FAILURE ACUTE 22 0.0033
255 EPISTAXIS 247 0.0033
256 MULTIPLE ORGAN DYSFUNCTION SYNDROME 93 0.0033
257 PSEUDOMONAS INFECTION 28 0.0033
258 CEREBRAL ATROPHY 13 0.0033
259 CREATININE RENAL CLEARANCE DECREASED 13 0.0032
260 THERAPY NON-RESPONDER 146 0.0032
261 HYPOMAGNESAEMIA 45 0.0032
262 CHOLESTASIS 62 0.0032
263 CYSTITIS HAEMORRHAGIC 13 0.0032
264 STAPHYLOCOCCAL BACTERAEMIA 14 0.0032
265 DYSPNOEA EXERTIONAL 121 0.0032
266 HAEMORRHAGE INTRACRANIAL 48 0.0032
267 PLEURISY 19 0.0032
268 ELECTROCARDIOGRAM QT PROLONGED 115 0.0032
269 HAEMORRHAGIC ANAEMIA 14 0.0032
270 PERIPHERAL ISCHAEMIA 13 0.0032
271 MOUTH ULCERATION 67 0.0032
272 CONTUSION 304 0.0032
273 BLOOD ALBUMIN DECREASED 25 0.0031
274 INTENTIONAL PRODUCT USE ISSUE 275 0.0031
275 LABORATORY TEST ABNORMAL 92 0.0031
276 NO THERAPEUTIC RESPONSE 38 0.0031
277 MITRAL VALVE INCOMPETENCE 35 0.0031
278 BONE PAIN 181 0.0031
279 RETINAL HAEMORRHAGE 22 0.0031
280 HYPERKERATOSIS 17 0.0031
281 INTERSTITIAL LUNG DISEASE 149 0.0031
282 INSURANCE ISSUE 47 0.0031
283 CEREBRAL INFARCTION 75 0.0031
284 ECCHYMOSIS 21 0.0031
285 THERAPY CESSATION 157 0.0031
286 CEREBRAL HAEMORRHAGE 109 0.0030
287 JAUNDICE 81 0.0030
288 HEPATIC STEATOSIS 56 0.0030
289 GINGIVAL BLEEDING 41 0.0030
290 PYELONEPHRITIS 26 0.0030
291 TRANSPLANT REJECTION 24 0.0030
292 ERYSIPELAS 15 0.0030
293 TOXIC SKIN ERUPTION 30 0.0030
294 PRODUCT SIZE ISSUE 16 0.0030
295 DUODENAL ULCER 21 0.0030
296 APHTHOUS ULCER 23 0.0030
297 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 15 0.0030
298 CARDIAC TAMPONADE 14 0.0029
299 ESCHERICHIA INFECTION 24 0.0029
300 GASTROINTESTINAL TOXICITY 14 0.0029
301 INTESTINAL ISCHAEMIA 16 0.0029
302 PULMONARY ARTERIAL HYPERTENSION 42 0.0029
303 HYPOXIA 102 0.0029
304 PRODUCT DOSE OMISSION ISSUE 850 0.0029
305 PERIORBITAL OEDEMA 15 0.0029
306 PULMONARY MASS 43 0.0029
307 LYMPHOCYTE COUNT DECREASED 51 0.0029
308 SEPTIC SHOCK 125 0.0029
309 ANGIOPATHY 16 0.0029
310 PULMONARY TOXICITY 20 0.0028
311 HEPATITIS CHOLESTATIC 17 0.0028
312 HYPERNATRAEMIA 14 0.0028
313 NEPHROGENIC ANAEMIA 13 0.0028
314 DERMATITIS EXFOLIATIVE 14 0.0028
315 ENTEROCOLITIS 16 0.0028
316 MALNUTRITION 31 0.0028
317 HERPES SIMPLEX 18 0.0028
318 LUNG INFECTION 43 0.0028
319 STAPHYLOCOCCAL INFECTION 91 0.0028
320 BLOOD CREATININE INCREASED 180 0.0028
321 SEPSIS 307 0.0027
322 ASPARTATE AMINOTRANSFERASE INCREASED 146 0.0027
323 URINE OUTPUT DECREASED 24 0.0027
324 ORAL CANDIDIASIS 36 0.0027
325 RENAL FAILURE CHRONIC 21 0.0027
326 INCREASED APPETITE 52 0.0027
327 STOMATITIS 165 0.0027
328 RESPIRATORY DISTRESS 75 0.0027
329 PYREXIA 940 0.0027
330 RESPIRATORY FAILURE 197 0.0027
331 TOXIC EPIDERMAL NECROLYSIS 41 0.0027
332 IMPAIRED HEALING 88 0.0027
333 PARTIAL SEIZURES 14 0.0027
334 HEPATITIS B 16 0.0027
335 TRICUSPID VALVE INCOMPETENCE 21 0.0026
336 MYOCARDIAL ISCHAEMIA 30 0.0026
337 STAPHYLOCOCCAL SEPSIS 13 0.0026
338 PNEUMONIA BACTERIAL 24 0.0026
339 BUNDLE BRANCH BLOCK RIGHT 12 0.0026
340 SKIN ATROPHY 15 0.0026
341 VENTRICULAR EXTRASYSTOLES 27 0.0026
342 ANAL ABSCESS 14 0.0026
343 MELAENA 57 0.0026
344 OFF LABEL USE 2262 0.0026
345 PERIPHERAL SENSORY NEUROPATHY 15 0.0026
346 CHOLELITHIASIS 84 0.0026
347 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 13 0.0026
348 TERMINAL STATE 17 0.0025
349 HOSPICE CARE 25 0.0025
350 VIRAL INFECTION 84 0.0025
351 TRANSAMINASES INCREASED 56 0.0025
352 PROTHROMBIN TIME PROLONGED 15 0.0025
353 FAILURE TO THRIVE 13 0.0025
354 CARDIOMYOPATHY 37 0.0025
355 ACUTE PULMONARY OEDEMA 14 0.0025
356 PETECHIAE 26 0.0025
357 FAECES SOFT 18 0.0025
358 ONYCHOCLASIS 17 0.0025
359 CARDIAC FAILURE 198 0.0025
360 ANAL INCONTINENCE 22 0.0024
361 EJECTION FRACTION DECREASED 38 0.0024
362 HAEMATOTOXICITY 23 0.0024
363 TREATMENT NONCOMPLIANCE 132 0.0024
364 RESPIRATORY SYNCYTIAL VIRUS INFECTION 21 0.0024
365 PULMONARY OEDEMA 108 0.0024
366 SKIN INFECTION 27 0.0024
367 BLOOD CALCIUM DECREASED 27 0.0024
368 PNEUMONIA 775 0.0024
369 DRUG INTOLERANCE 231 0.0024
370 BLOOD SODIUM DECREASED 45 0.0024
371 HEPATIC FUNCTION ABNORMAL 89 0.0024
372 IMMUNOSUPPRESSION 21 0.0024
373 ATELECTASIS 23 0.0024
374 ABDOMINAL DISCOMFORT 399 0.0024
375 PURPURA 21 0.0024
376 FAECALOMA 13 0.0024
377 MULTI-ORGAN FAILURE 41 0.0024
378 HAEMODYNAMIC INSTABILITY 18 0.0024
379 LEUKOPENIA 118 0.0024
380 ABDOMINAL PAIN UPPER 483 0.0023
381 RENAL TUBULAR NECROSIS 23 0.0023
382 NECROSIS 13 0.0023
383 CARDIAC FLUTTER 15 0.0023
384 HYPOALBUMINAEMIA 18 0.0023
385 DISEASE PROGRESSION 273 0.0023
386 BACTERIAL INFECTION 43 0.0023
387 CHROMATURIA 52 0.0023
388 PNEUMOCYSTIS JIROVECII PNEUMONIA 23 0.0023
389 HAEMATEMESIS 58 0.0023
390 OEDEMA PERIPHERAL 276 0.0023
391 RENAL IMPAIRMENT 190 0.0023
392 SUBARACHNOID HAEMORRHAGE 23 0.0023
393 MALIGNANT NEOPLASM PROGRESSION 231 0.0023
394 HYPERKALAEMIA 79 0.0023
395 HYPOKALAEMIA 103 0.0022
396 DIARRHOEA 1433 0.0022
397 SHOCK HAEMORRHAGIC 18 0.0022
398 NEUTROPENIA 300 0.0022
399 PREMATURE DELIVERY 35 0.0022
400 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
401 MATERNAL EXPOSURE BEFORE PREGNANCY 15 0.0022
402 DECREASED APPETITE 509 0.0022
403 NEPHROTIC SYNDROME 15 0.0022
404 SKIN LESION 60 0.0022
405 LYMPHOEDEMA 15 0.0022
406 BLOOD PRESSURE DIASTOLIC DECREASED 16 0.0022
407 OSTEONECROSIS 71 0.0022
408 NEUTROPHIL COUNT DECREASED 88 0.0022
409 HEPATIC FAILURE 65 0.0022
410 POST PROCEDURAL HAEMORRHAGE 25 0.0021
411 DIARRHOEA HAEMORRHAGIC 20 0.0021
412 THERAPY INTERRUPTED 152 0.0021
413 RHINITIS 17 0.0021
414 HAEMORRHAGE 220 0.0021
415 TROPONIN INCREASED 16 0.0021
416 ALANINE AMINOTRANSFERASE INCREASED 129 0.0021
417 LIVER DISORDER 93 0.0021
418 ABDOMINAL PAIN 487 0.0021
419 SKIN HAEMORRHAGE 31 0.0021
420 FLUID RETENTION 106 0.0021
421 PRODUCT DOSE OMISSION IN ERROR 59 0.0021
422 THROMBOSIS 167 0.0021
423 RENAL FAILURE ACUTE 88 0.0021
424 RASH MACULO-PAPULAR 46 0.0021
425 MUSCULOSKELETAL CHEST PAIN 32 0.0021
426 CELLULITIS 104 0.0021
427 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 35 0.0021
428 ASTHENIA 774 0.0021
429 LYMPHOPENIA 29 0.0020
430 HAEMORRHAGIC STROKE 16 0.0020
431 OEDEMA 111 0.0020
432 GASTROINTESTINAL HAEMORRHAGE 171 0.0020
433 TORSADE DE POINTES 16 0.0020
434 SKIN DISCOLOURATION 93 0.0020
435 HEPATOTOXICITY 45 0.0020
436 TRANSIENT ISCHAEMIC ATTACK 68 0.0020
437 HYPERTRANSAMINASAEMIA 14 0.0020
438 FATIGUE 1563 0.0020
439 RENAL DISORDER 93 0.0020
440 DEHYDRATION 266 0.0020
441 GAMMA-GLUTAMYLTRANSFERASE INCREASED 44 0.0020
442 PATHOGEN RESISTANCE 18 0.0020
443 BLOOD MAGNESIUM DECREASED 17 0.0020
444 HEPATIC CYTOLYSIS 25 0.0020
445 SLUGGISHNESS 20 0.0020
446 PULMONARY EMBOLISM 186 0.0020
447 GASTRIC ULCER 37 0.0019
448 MENTAL STATUS CHANGES 54 0.0019
449 MYELOSUPPRESSION 70 0.0019
450 NAIL DISORDER 17 0.0019
451 DECREASED IMMUNE RESPONSIVENESS 19 0.0019
452 DERMATITIS BULLOUS 14 0.0019
453 ACUTE CORONARY SYNDROME 16 0.0019
454 SKIN LACERATION 21 0.0019
455 EATING DISORDER 41 0.0019
456 GENERAL PHYSICAL CONDITION ABNORMAL 13 0.0019
457 TACHYPNOEA 26 0.0019
458 ASCITES 56 0.0019
459 FLATULENCE 108 0.0019
460 BRAIN OEDEMA 24 0.0019
461 INFARCTION 13 0.0019
462 LYMPHADENOPATHY 67 0.0019
463 RENAL CYST 15 0.0019
464 HYPERCHOLESTEROLAEMIA 18 0.0019
465 HAEMOPTYSIS 52 0.0019
466 HYPONATRAEMIA 105 0.0019
467 HERPES ZOSTER 107 0.0019
468 FLUID OVERLOAD 27 0.0019
469 CHOLECYSTITIS 22 0.0018
470 FAECES DISCOLOURED 40 0.0018
471 HEPATOCELLULAR INJURY 26 0.0018
472 WOUND INFECTION 20 0.0018
473 TENDERNESS 19 0.0018
474 LIVER FUNCTION TEST ABNORMAL 53 0.0018
475 PULMONARY CONGESTION 24 0.0018
476 NEUTROPENIC SEPSIS 13 0.0018
477 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0018
478 SPINAL COMPRESSION FRACTURE 15 0.0018
479 POOR QUALITY SLEEP 39 0.0018
480 INFECTION 262 0.0018
481 APPETITE DISORDER 12 0.0018
482 ATRIAL FIBRILLATION 176 0.0018
483 CONSTIPATION 393 0.0018
484 DYSPHAGIA 171 0.0018
485 ORAL DISCOMFORT 25 0.0018
486 EYE HAEMORRHAGE 24 0.0018
487 SPINAL PAIN 21 0.0018
488 ABDOMINAL DISTENSION 187 0.0018
489 DEMENTIA 50 0.0018
490 GASTRITIS 47 0.0018
491 RASH PUSTULAR 13 0.0018
492 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
493 HEMIPARESIS 30 0.0018
494 ACUTE KIDNEY INJURY 271 0.0018
495 PAIN IN EXTREMITY 521 0.0018
496 PNEUMONITIS 48 0.0018
497 BLOOD POTASSIUM DECREASED 53 0.0018
498 PREMATURE BABY 53 0.0018
499 HEPATITIS 45 0.0018
500 VENTRICULAR TACHYCARDIA 29 0.0018
501 VITAMIN D DECREASED 15 0.0018
502 GENERAL PHYSICAL HEALTH DETERIORATION 202 0.0017
503 TEMPERATURE INTOLERANCE 18 0.0017
504 CARDIAC FAILURE CONGESTIVE 140 0.0017
505 ANURIA 15 0.0017
506 BACK PAIN 404 0.0017
507 IRON DEFICIENCY ANAEMIA 16 0.0017
508 JOINT INJURY 37 0.0017
509 C-REACTIVE PROTEIN INCREASED 63 0.0017
510 LIMB INJURY 47 0.0017
511 ILL-DEFINED DISORDER 105 0.0017
512 PERICARDITIS 29 0.0017
513 PRODUCT DISTRIBUTION ISSUE 16 0.0017
514 BRAIN FOG 27 0.0017
515 POST PROCEDURAL INFECTION 14 0.0017
516 DECUBITUS ULCER 14 0.0017
517 HEADACHE 1073 0.0017
518 POLYURIA 14 0.0017
519 HYPERTHERMIA 13 0.0017
520 ACUTE MYOCARDIAL INFARCTION 50 0.0017
521 THERAPEUTIC RESPONSE UNEXPECTED 76 0.0017
522 OCULAR DISCOMFORT 19 0.0017
523 DEVICE RELATED INFECTION 26 0.0017
524 FEELING COLD 47 0.0017
525 EMPHYSEMA 17 0.0017
526 WEIGHT INCREASED 377 0.0017
527 WOUND 47 0.0017
528 ISCHAEMIC STROKE 30 0.0017
529 NAUSEA 1328 0.0017
530 GASTROINTESTINAL INFECTION 15 0.0017
531 ENCEPHALOPATHY 41 0.0017
532 SCAB 19 0.0017
533 HAEMATURIA 57 0.0017
534 INTERNAL HAEMORRHAGE 19 0.0017
535 MYOCARDITIS 19 0.0017
536 SINUS BRADYCARDIA 16 0.0017
537 OXYGEN SATURATION DECREASED 93 0.0017
538 CHEST PAIN 306 0.0017
539 HYPERSOMNIA 47 0.0016
540 ELECTROLYTE IMBALANCE 19 0.0016
541 ANOREXIA 21 0.0016
542 FREQUENT BOWEL MOVEMENTS 44 0.0016
543 CARDIO-RESPIRATORY ARREST 68 0.0016
544 SEASONAL ALLERGY 23 0.0016
545 WEIGHT DECREASED 453 0.0016
546 VENTRICULAR FIBRILLATION 18 0.0016
547 COAGULOPATHY 27 0.0016
548 PULMONARY FIBROSIS 31 0.0016
549 RESPIRATORY TRACT INFECTION 42 0.0016
550 COLON CANCER 24 0.0016
551 NEPHROPATHY 15 0.0016
552 GASTROENTERITIS VIRAL 29 0.0016
553 UPPER GASTROINTESTINAL HAEMORRHAGE 27 0.0016
554 HYPOPHAGIA 41 0.0016
555 PNEUMONIA ASPIRATION 40 0.0016
556 ATAXIA 19 0.0016
557 LACERATION 15 0.0016
558 ARTERIOSCLEROSIS 15 0.0016
559 MATERNAL EXPOSURE DURING PREGNANCY 142 0.0016
560 RENAL FAILURE 211 0.0016
561 SKIN DISORDER 53 0.0016
562 RASH PRURITIC 86 0.0016
563 HYPOCALCAEMIA 30 0.0016
564 FRACTURE 30 0.0016
565 LUNG DISORDER 77 0.0016
566 ACIDOSIS 12 0.0016
567 MALIGNANT MELANOMA 21 0.0016
568 URINARY TRACT INFECTION 267 0.0016
569 AGRANULOCYTOSIS 29 0.0016
570 DIFFUSE LARGE B-CELL LYMPHOMA 12 0.0016
571 WHEEZING 92 0.0015
572 DIALYSIS 22 0.0015
573 RETCHING 33 0.0015
574 DIZZINESS POSTURAL 15 0.0015
575 CAESAREAN SECTION 18 0.0015
576 CHILLS 181 0.0015
577 FACE OEDEMA 26 0.0015
578 CANDIDA INFECTION 26 0.0015
579 ORAL HERPES 30 0.0015
580 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 84 0.0015
581 FUNGAL INFECTION 51 0.0015
582 GAIT INABILITY 51 0.0015
583 NEOPLASM PROGRESSION 53 0.0015
584 PERIPHERAL SWELLING 234 0.0015
585 LIGAMENT SPRAIN 15 0.0015
586 INCONTINENCE 16 0.0015
587 NEOPLASM MALIGNANT 100 0.0015
588 DIZZINESS 741 0.0015
589 EOSINOPHILIA 26 0.0015
590 NEPHROLITHIASIS 68 0.0015
591 FEEDING DISORDER 30 0.0015
592 DEEP VEIN THROMBOSIS 96 0.0015
593 COUGH 414 0.0015
594 CYSTITIS 47 0.0015
595 BLOOD URINE PRESENT 28 0.0015
596 THERAPY PARTIAL RESPONDER 23 0.0015
597 DISEASE RECURRENCE 70 0.0015
598 PALLOR 40 0.0015
599 VOMITING 691 0.0015
600 DYSPNOEA 831 0.0015
601 HIATUS HERNIA 19 0.0015
602 OESOPHAGITIS 16 0.0015
603 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 104 0.0015
604 ASPIRATION 16 0.0015
605 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
606 PERIPHERAL COLDNESS 20 0.0015
607 NODULE 19 0.0015
608 URINARY INCONTINENCE 43 0.0014
609 MEMORY IMPAIRMENT 199 0.0014
610 LOCALISED INFECTION 35 0.0014
611 HYPOKINESIA 21 0.0014
612 EMBOLISM 12 0.0014
613 IMMUNE SYSTEM DISORDER 19 0.0014
614 COVID-19 PNEUMONIA 17 0.0014
615 GASTROENTERITIS 21 0.0014
616 METABOLIC ACIDOSIS 46 0.0014
617 INTERNATIONAL NORMALISED RATIO INCREASED 41 0.0014
618 INFLUENZA 160 0.0014
619 HAEMATOCHEZIA 79 0.0014
620 LIP DRY 13 0.0014
621 MASS 20 0.0014
622 BURNING SENSATION 100 0.0014
623 PANCREATITIS ACUTE 32 0.0014
624 PAIN 872 0.0014
625 MALAISE 620 0.0014
626 HEAD DISCOMFORT 25 0.0014
627 UROSEPSIS 13 0.0014
628 HEPATIC ENZYME INCREASED 96 0.0014
629 BURSITIS 17 0.0014
630 FALL 465 0.0014
631 HYPOTENSION 279 0.0014
632 THERAPEUTIC RESPONSE DECREASED 84 0.0014
633 ABORTION INDUCED 13 0.0014
634 OSTEOMYELITIS 25 0.0014
635 VERTIGO 84 0.0014
636 CATARACT 82 0.0014
637 SPINAL DISORDER 13 0.0014
638 BLOOD PRESSURE ABNORMAL 27 0.0014
639 CARDIAC ARREST 112 0.0014
640 LETHARGY 78 0.0014
641 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 65 0.0014
642 HYPERGLYCAEMIA 49 0.0013
643 ABDOMINAL PAIN LOWER 34 0.0013
644 MUSCLE ATROPHY 17 0.0013
645 SINUS TACHYCARDIA 19 0.0013
646 NEPHROPATHY TOXIC 15 0.0013
647 THROMBOTIC MICROANGIOPATHY 13 0.0013
648 VITAMIN D DEFICIENCY 13 0.0013
649 SINUS CONGESTION 18 0.0013
650 INTESTINAL OBSTRUCTION 50 0.0013
651 ANGINA PECTORIS 38 0.0013
652 MYDRIASIS 17 0.0013
653 DRUG DOSE OMISSION 219 0.0013
654 BODY TEMPERATURE INCREASED 27 0.0013
655 RENAL PAIN 14 0.0013
656 POLLAKIURIA 55 0.0013
657 PROTEINURIA 25 0.0013
658 MICTURITION URGENCY 15 0.0013
659 ARRHYTHMIA 62 0.0013
660 ARTHRALGIA 543 0.0013
661 LIVER FUNCTION TEST INCREASED 28 0.0013
662 DYSURIA 48 0.0013
663 DYSSTASIA 38 0.0013
664 METASTASES TO LUNG 15 0.0013
665 HYPERTENSION 275 0.0013
666 HYPERCALCAEMIA 16 0.0013
667 ORAL PAIN 29 0.0013
668 RASH PAPULAR 29 0.0013
669 CEREBROVASCULAR ACCIDENT 219 0.0013
670 GASTROOESOPHAGEAL REFLUX DISEASE 104 0.0013
671 PHARYNGITIS 16 0.0013
672 DERMATITIS 27 0.0013
673 SARS-COV-2 TEST POSITIVE 17 0.0013
674 HAEMORRHOIDS 25 0.0013
675 DRY THROAT 13 0.0013
676 HEPATIC CIRRHOSIS 24 0.0013
677 CHRONIC KIDNEY DISEASE 97 0.0013
678 TACHYCARDIA 113 0.0013
679 QUALITY OF LIFE DECREASED 17 0.0013
680 HEAD INJURY 40 0.0013
681 MUSCLE SPASMS 231 0.0013
682 MUSCULAR WEAKNESS 143 0.0013
683 POLYNEUROPATHY 15 0.0013
684 PALPITATIONS 146 0.0012
685 LUNG NEOPLASM MALIGNANT 51 0.0012
686 EAR PAIN 24 0.0012
687 DEATH 1062 0.0012
688 MYALGIA 209 0.0012
689 CHOLECYSTECTOMY 14 0.0012
690 BODY TEMPERATURE DECREASED 12 0.0012
691 COORDINATION ABNORMAL 17 0.0012
692 NEOPLASM 14 0.0012
693 GASTRIC HAEMORRHAGE 14 0.0012
694 RECTAL HAEMORRHAGE 52 0.0012
695 RESTLESS LEGS SYNDROME 22 0.0012
696 TOOTH EXTRACTION 15 0.0012
697 EYELID OEDEMA 14 0.0012
698 MUSCULOSKELETAL PAIN 63 0.0012
699 BRONCHITIS 89 0.0012
700 PHARYNGITIS STREPTOCOCCAL 13 0.0012
701 ABORTION SPONTANEOUS 48 0.0012
702 LIMB DISCOMFORT 37 0.0012
703 SOMNOLENCE 240 0.0012
704 CARDIOGENIC SHOCK 17 0.0012
705 HOSPITALISATION 182 0.0012
706 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
707 ABASIA 29 0.0012
708 HYPERLIPIDAEMIA 14 0.0012
709 UPPER RESPIRATORY TRACT INFECTION 54 0.0012
710 DRUG INTERACTION 185 0.0012
711 LYMPHOMA 18 0.0012
712 PRURITUS 447 0.0012
713 NECK PAIN 65 0.0012
714 INFLAMMATION 60 0.0012
715 UNRESPONSIVE TO STIMULI 30 0.0012
716 RASH GENERALISED 30 0.0012
717 NEUROPATHY PERIPHERAL 110 0.0012
718 CORONARY ARTERY DISEASE 35 0.0012
719 ALTERED STATE OF CONSCIOUSNESS 25 0.0012
720 TINNITUS 53 0.0012
721 NEURALGIA 28 0.0012
722 PREGNANCY 23 0.0011
723 DYSPEPSIA 113 0.0011
724 RASH MACULAR 40 0.0011
725 FEELING ABNORMAL 273 0.0011
726 ERUCTATION 22 0.0011
727 PANCREATITIS 60 0.0011
728 PNEUMOTHORAX 18 0.0011
729 BLINDNESS UNILATERAL 16 0.0011
730 OROPHARYNGEAL PAIN 105 0.0011
731 RASH 492 0.0011
732 DIVERTICULITIS 31 0.0011
733 GASTROINTESTINAL DISORDER 100 0.0011
734 BLOOD CHOLESTEROL INCREASED 52 0.0011
735 DEAFNESS 29 0.0011
736 FOOT FRACTURE 21 0.0011
737 TOOTHACHE 20 0.0011
738 MUSCULOSKELETAL DISCOMFORT 19 0.0011
739 PRODUCT USE IN UNAPPROVED INDICATION 273 0.0011
740 BALANCE DISORDER 95 0.0011
741 BONE DISORDER 20 0.0011
742 CYTOKINE RELEASE SYNDROME 22 0.0011
743 SYNCOPE 109 0.0011
744 CONFUSIONAL STATE 176 0.0011
745 PRODUCT ADMINISTRATION ERROR 22 0.0011
746 RASH ERYTHEMATOUS 52 0.0011
747 TREATMENT FAILURE 90 0.0011
748 NEUROTOXICITY 19 0.0011
749 COVID-19 190 0.0011
750 AGEUSIA 27 0.0011
751 METASTASES TO LIVER 19 0.0011
752 CARDIAC DISORDER 101 0.0011
753 ALOPECIA 212 0.0011
754 RESPIRATORY DISORDER 32 0.0011
755 RIB FRACTURE 22 0.0011
756 PRODUCTIVE COUGH 51 0.0011
757 SCIATICA 17 0.0011
758 DYSGEUSIA 79 0.0011
759 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
760 DRUG-INDUCED LIVER INJURY 33 0.0011
761 URINARY RETENTION 35 0.0010
762 BACK DISORDER 17 0.0010
763 SHOCK 24 0.0010
764 HYPOAESTHESIA 156 0.0010
765 BLOOD PRESSURE DECREASED 69 0.0010
766 ARTHRITIS 81 0.0010
767 COLITIS 39 0.0010
768 APATHY 15 0.0010
769 APHASIA 31 0.0010
770 HIP FRACTURE 33 0.0010
771 SWELLING 96 0.0010
772 BLOOD PRESSURE SYSTOLIC INCREASED 20 0.0010
773 GASTRIC DISORDER 35 0.0010
774 HYPERHIDROSIS 131 0.0010
775 DRUG ERUPTION 18 0.0010
776 CONDITION AGGRAVATED 308 0.0010
777 DRY MOUTH 82 0.0010
778 GALLBLADDER DISORDER 18 0.0010
779 HYPOAESTHESIA ORAL 15 0.0010
780 SLEEP DISORDER 70 0.0010
781 HEART RATE INCREASED 98 0.0010
782 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23 0.0010
783 ILLNESS 101 0.0010
784 DYSPHONIA 57 0.0010
785 PHOTOSENSITIVITY REACTION 16 0.0010
786 HYPERTHYROIDISM 14 0.0010
787 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
788 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
789 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 173 0.0010
790 PHOTOPHOBIA 18 0.0010
791 ASTHMA 108 0.0010
792 HOT FLUSH 72 0.0010
793 DRUG TOXICITY 13 0.0010
794 THIRST 17 0.0010
795 BLISTER 53 0.0009
796 EAR INFECTION 25 0.0009
797 SWELLING FACE 61 0.0009
798 GAIT DISTURBANCE 179 0.0009
799 END STAGE RENAL DISEASE 17 0.0009
800 PRESCRIBED OVERDOSE 18 0.0009
801 HEART RATE IRREGULAR 21 0.0009
802 PAIN OF SKIN 25 0.0009
803 CARPAL TUNNEL SYNDROME 13 0.0009
804 CHOKING 18 0.0009
805 OSTEOPENIA 14 0.0009
806 AMNESIA 60 0.0009
807 VISUAL IMPAIRMENT 114 0.0009
808 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 48 0.0009
809 PAIN IN JAW 26 0.0009
810 KIDNEY INFECTION 18 0.0009
811 HIP ARTHROPLASTY 14 0.0009
812 FEELING HOT 56 0.0009
813 ADVERSE EVENT 84 0.0009
814 DISORIENTATION 36 0.0009
815 CHEST DISCOMFORT 93 0.0009
816 DEPRESSED MOOD 48 0.0009
817 TENDONITIS 14 0.0009
818 INSOMNIA 240 0.0009
819 TOOTH DISORDER 20 0.0009
820 FOETAL EXPOSURE DURING PREGNANCY 73 0.0009
821 NASOPHARYNGITIS 164 0.0009
822 SINUSITIS 91 0.0009
823 BRADYCARDIA 47 0.0009
824 ROAD TRAFFIC ACCIDENT 37 0.0009
825 INTENTIONAL PRODUCT MISUSE 77 0.0009
826 ACUTE HEPATIC FAILURE 12 0.0009
827 BLOOD PRESSURE FLUCTUATION 21 0.0009
828 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
829 BLOOD CREATINE PHOSPHOKINASE INCREASED 25 0.0009
830 DEPRESSION 197 0.0009
831 THINKING ABNORMAL 16 0.0009
832 LOSS OF CONSCIOUSNESS 110 0.0009
833 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25 0.0009
834 INTENTIONAL DOSE OMISSION 24 0.0008
835 BRONCHOSPASM 12 0.0008
836 PRODUCT USE ISSUE 158 0.0008
837 ANKLE FRACTURE 13 0.0008
838 FEMUR FRACTURE 26 0.0008
839 DELIRIUM 29 0.0008
840 DEPRESSED LEVEL OF CONSCIOUSNESS 33 0.0008
841 NASAL CONGESTION 49 0.0008
842 LACTIC ACIDOSIS 27 0.0008
843 EYE SWELLING 31 0.0008
844 SWOLLEN TONGUE 26 0.0008
845 OSTEOPOROSIS 34 0.0008
846 HEART RATE DECREASED 29 0.0008
847 MUSCLE TWITCHING 19 0.0008
848 DRY SKIN 110 0.0008
849 BLOOD GLUCOSE ABNORMAL 15 0.0008
850 DIPLOPIA 21 0.0008
851 VISION BLURRED 111 0.0008
852 HALLUCINATION, VISUAL 17 0.0008
853 JOINT SWELLING 97 0.0008
854 UPPER LIMB FRACTURE 16 0.0008
855 SPINAL FRACTURE 16 0.0008
856 MOBILITY DECREASED 57 0.0008
857 BLOOD PRESSURE INCREASED 121 0.0008
858 DRUG LEVEL INCREASED 13 0.0008
859 PRESYNCOPE 19 0.0008
860 PRODUCT PRESCRIBING ISSUE 17 0.0008
861 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
862 COMA 37 0.0008
863 HERNIA 15 0.0008
864 RHINORRHOEA 50 0.0008
865 OSTEONECROSIS OF JAW 19 0.0008
866 SKIN FISSURES 15 0.0008
867 PARAESTHESIA 119 0.0008
868 PRODUCT PRESCRIBING ERROR 18 0.0008
869 MEDICATION ERROR 42 0.0008
870 OSTEOARTHRITIS 32 0.0008
871 TYPE 2 DIABETES MELLITUS 25 0.0007
872 DRY EYE 37 0.0007
873 INFLUENZA LIKE ILLNESS 61 0.0007
874 SKIN EXFOLIATION 62 0.0007
875 DIABETES MELLITUS 56 0.0007
876 ABNORMAL BEHAVIOUR 29 0.0007
877 HALLUCINATION 55 0.0007
878 RESPIRATORY ARREST 20 0.0007
879 JOINT STIFFNESS 19 0.0007
880 HYPOTHYROIDISM 23 0.0007
881 STEVENS-JOHNSON SYNDROME 16 0.0007
882 ARTHROPATHY 40 0.0007
883 ANXIETY 204 0.0007
884 GLOSSODYNIA 16 0.0007
885 DRUG INEFFECTIVE 941 0.0007
886 EMOTIONAL DISORDER 22 0.0007
887 THROAT IRRITATION 32 0.0007
888 TREMOR 118 0.0007
889 GASTRIC CANCER 18 0.0007
890 MUSCULOSKELETAL STIFFNESS 62 0.0007
891 COGNITIVE DISORDER 33 0.0007
892 HYPERSENSITIVITY 131 0.0007
893 NERVOUS SYSTEM DISORDER 22 0.0007
894 DISCOMFORT 43 0.0007
895 ADVERSE DRUG REACTION 63 0.0007
896 LACRIMATION INCREASED 21 0.0007
897 TASTE DISORDER 14 0.0007
898 SPEECH DISORDER 36 0.0007
899 EPILEPSY 21 0.0007
900 MOVEMENT DISORDER 22 0.0007
901 CONVULSION 39 0.0007
902 SLEEP APNOEA SYNDROME 13 0.0007
903 MIGRAINE 65 0.0007
904 MYOCARDIAL INFARCTION 118 0.0007
905 CARDIOVASCULAR DISORDER 17 0.0007
906 DISTURBANCE IN ATTENTION 36 0.0007
907 AGITATION 49 0.0007
908 PLASMA CELL MYELOMA 26 0.0007
909 ERECTILE DYSFUNCTION 17 0.0007
910 LOWER RESPIRATORY TRACT INFECTION 30 0.0007
911 INCORRECT DOSE ADMINISTERED 150 0.0007
912 EYE PAIN 37 0.0007
913 ERYTHEMA 134 0.0007
914 PRESCRIBED UNDERDOSE 13 0.0007
915 HYPOACUSIS 28 0.0006
916 DRUG EXPOSURE DURING PREGNANCY 22 0.0006
917 PRODUCT PHYSICAL ISSUE 13 0.0006
918 PRODUCT DISPENSING ERROR 14 0.0006
919 HYPOGLYCAEMIA 31 0.0006
920 MENTAL IMPAIRMENT 15 0.0006
921 INFUSION RELATED REACTION 41 0.0006
922 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 44 0.0006
923 IRRITABILITY 37 0.0006
924 SEIZURE 71 0.0006
925 SURGERY 36 0.0006
926 URTICARIA 102 0.0006
927 RENAL INJURY 18 0.0006
928 PRURITUS GENERALISED 13 0.0006
929 DYSKINESIA 24 0.0006
930 BLINDNESS 24 0.0006
931 SNEEZING 13 0.0006
932 PROCEDURAL PAIN 16 0.0006
933 NERVOUSNESS 30 0.0006
934 ACCIDENTAL OVERDOSE 21 0.0006
935 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 115 0.0006
936 ACNE 43 0.0006
937 COLITIS ULCERATIVE 25 0.0006
938 EYE DISORDER 18 0.0005
939 EXPOSURE DURING PREGNANCY 34 0.0005
940 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0005
941 VISUAL ACUITY REDUCED 18 0.0005
942 DYSARTHRIA 20 0.0005
943 WITHDRAWAL SYNDROME 21 0.0005
944 ECZEMA 26 0.0005
945 SKIN IRRITATION 22 0.0005
946 UNDERDOSE 35 0.0005
947 MOOD ALTERED 13 0.0005
948 ABNORMAL DREAMS 13 0.0005
949 MOOD SWINGS 15 0.0005
950 RESTLESSNESS 17 0.0005
951 OCULAR HYPERAEMIA 22 0.0005
952 TOXICITY TO VARIOUS AGENTS 78 0.0005
953 MENTAL DISORDER 20 0.0005
954 RHEUMATOID ARTHRITIS 52 0.0005
955 EXPIRED PRODUCT ADMINISTERED 15 0.0005
956 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
957 PANCREATIC CARCINOMA 13 0.0004
958 ANGER 15 0.0004
959 WRONG TECHNIQUE IN DRUG USAGE PROCESS 16 0.0004
960 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
961 DRUG ADMINISTRATION ERROR 13 0.0004
962 UNEVALUABLE EVENT 32 0.0004
963 LIP SWELLING 14 0.0004
964 EYE IRRITATION 24 0.0004
965 FLUSHING 41 0.0004
966 BLOOD GLUCOSE INCREASED 75 0.0004
967 CRYING 14 0.0004
968 ANGIOEDEMA 17 0.0004
969 AGGRESSION 19 0.0004
970 VAGINAL HAEMORRHAGE 15 0.0003
971 INJURY 24 0.0003
972 PROSTATE CANCER 27 0.0003
973 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
974 PRODUCT SUBSTITUTION ISSUE 19 0.0003
975 BREAST CANCER 30 0.0003
976 EXTRA DOSE ADMINISTERED 13 0.0003
977 BLOOD GLUCOSE DECREASED 15 0.0003
978 EMOTIONAL DISTRESS 36 0.0003
979 SUICIDAL IDEATION 26 0.0003
980 OVERDOSE 57 0.0003
981 SKIN BURNING SENSATION 18 0.0003
982 ANAPHYLACTIC REACTION 13 0.0002
983 BLADDER CANCER 13 0.0002
984 NO ADVERSE EVENT 39 0.0002
985 PRODUCT STORAGE ERROR 18 0.0002
986 PRODUCT QUALITY ISSUE 27 0.0002
987 INJECTION SITE BRUISING 15 0.0002
988 INJECTION SITE ERYTHEMA 21 0.0002
989 DEVICE ISSUE 13 0.0001
990 PSORIASIS 17 0.0001
991 INJECTION SITE PAIN 39 0.0001
992 DRUG DEPENDENCE 15 0.0001